Publications by authors named "J De Avila"

Context: Guidelines for use of injectable estradiol esters (valerate [EV] and cypionate [EC]) among transgender and gender diverse (TGD) individuals designated male at birth vary considerably, with many providers noting supraphysiologic serum estradiol concentrations based on current dosing recommendations.

Objectives: 1. Determine dose of injectable estradiol (subcutaneous [SC] and intramuscular [IM]) needed to reach guideline-recommended estradiol concentrations for TGD adults using EC/EV.

View Article and Find Full Text PDF

Cisplatin (CP) is an antineoplastic drug associated with various cytotoxic adverse effects, including hepatotoxicity. Exercise training may offer hepatoprotection by improving redox status. This study compared the effects of light-intensity continuous training (LICT), moderate-intensity continuous training (MICT), and high-intensity interval training (HIIT) on CP-induced hepatotoxicity in female Wistar rats.

View Article and Find Full Text PDF

Background: Lung cancer screening (LCS) offers a teachable moment for smoking cessation. This study assesses whether individual- or neighborhood-level SES is associated with tobacco abstinence and completion of a smoking cessation intervention in the LCS context.

Methods: Secondary analysis of a clinical trial (NCT03611881) that tested the effectiveness of smoking cessation treatment for smokers scheduled for LCS (N = 615) in eastern Massachusetts, USA from 2019 to 2024.

View Article and Find Full Text PDF

Purpose: The COVID-19 pandemic created significant disruptions in the diagnosis and treatment of breast cancer (BC). Several public health measures were taken with limited evidence on their potential impact. In this observational study, we sought to compare the incidence of BC, treatment patterns, and mortality during 2020 versus 2018 and 2019.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to find a link between fecal calprotectin (FC) levels and intestinal inflammation in patients with spondyloarthritis (SpA) who do not have inflammatory bowel disease.
  • Out of 180 SpA patients, approximately 27% exhibited positive fecal calprotectin and about 16% showed high levels, with significant associations found between higher FC levels and measures of disease activity and abdominal symptoms.
  • The results suggest that elevated FC levels, especially in patients showing loss of vascular pattern in the ileum, could serve as a useful biomarker for managing SpA, indicating a common immune response related to chronic inflammation.
View Article and Find Full Text PDF